141 related articles for article (PubMed ID: 28609136)
1. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature.
Bardoli AD; Taylor WSJ; Mahmalji W
Aging Male; 2017 Sep; 20(3):192-197. PubMed ID: 28609136
[TBL] [Abstract][Full Text] [Related]
2. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
Pham H; Sharma P
Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
[TBL] [Abstract][Full Text] [Related]
3. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
5. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP.
Falahatkar S; Mokhtari G; Moghaddam KG; Asadollahzade A; Farzan A; Shahab E; Ghasemi A; Allahkhah A; Esmaeili S
Int Braz J Urol; 2014; 40(3):346-55. PubMed ID: 25010300
[TBL] [Abstract][Full Text] [Related]
6. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population.
Wang MQ; Guo LP; Zhang GD; Yuan K; Li K; Duan F; Yan JY; Wang Y; Kang HY; Wang ZJ
BMC Urol; 2015 Apr; 15():33. PubMed ID: 25887036
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life in patients with lower urinary tract symptoms after TURP for benign prostatic hyperplasia].
Pushkar DY; Bernikov AN; Khodyreva LA; Dudareva AA; Al'-Shukri SK; Amdii RE; Aboyan IA; Shiranov KA; Medvedev VL; Efremov ME
Urologiia; 2018 Mar; (1):53-61. PubMed ID: 29634135
[TBL] [Abstract][Full Text] [Related]
8. The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance.
Ray A; Morgan H; Wilkes A; Carter K; Carolan-Rees G
Appl Health Econ Health Policy; 2016 Oct; 14(5):515-26. PubMed ID: 26832146
[TBL] [Abstract][Full Text] [Related]
9. [Does the surgeon have an influence on clinical voiding parameters and postoperative sexual function after TURP?].
Friedhelm B; Berner L; Dechet C; Presson A; Pycha A
Aktuelle Urol; 2013 Sep; 44(5):370-4. PubMed ID: 24043536
[TBL] [Abstract][Full Text] [Related]
10. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of the urolift® system for the treatment of benign prostate hyperplasia symptoms: systematic review.
Sánchez-Gómez LM; Polo-deSantos M; Gómez-Sancha F; Luengo-Matos S
Actas Urol Esp; 2015 Jun; 39(5):311-9. PubMed ID: 25260950
[TBL] [Abstract][Full Text] [Related]
12. [Are the UroLift(®) implants an alternative for the treatment of benign prostatic hyperplasia? Short-term results and predictive factors of failure].
Beurrier S; Peyromaure M; Belas O; Barry Delongchamps N
Prog Urol; 2015 Jul; 25(9):523-9. PubMed ID: 25934591
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
Küpeli S; Yilmaz E; Soygür T; Budak M
J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
[TBL] [Abstract][Full Text] [Related]
14. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Woo HH; Bolton DM; Laborde E; Jack G; Chin PT; Rashid P; Thavaseelan J; McVary KT
J Sex Med; 2012 Feb; 9(2):568-75. PubMed ID: 22172161
[TBL] [Abstract][Full Text] [Related]
15. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
[TBL] [Abstract][Full Text] [Related]
16. UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update.
Knight L; Dale M; Cleves A; Pelekanou C; Morris R
Appl Health Econ Health Policy; 2022 Sep; 20(5):669-680. PubMed ID: 35843995
[TBL] [Abstract][Full Text] [Related]
17. Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients.
Pavone C; Abbadessa D; Scaduto G; Caruana G; Scalici Gesolfo C; Fontana D; Vaccarella L
Arch Ital Urol Androl; 2015 Mar; 87(1):8-13. PubMed ID: 25847889
[TBL] [Abstract][Full Text] [Related]
18. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.
Wei Y; Xu N; Chen SH; Li XD; Zheng QS; Lin YZ; Xue XY
Int Braz J Urol; 2016; 42(4):747-56. PubMed ID: 27564286
[TBL] [Abstract][Full Text] [Related]
19. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
Volpe A; Billia M; Quaglia M; Vidali M; Marchioro G; Ceratti G; Sogni F; De Lorenzis E; De Angelis P; Airoldi A; Stratta P; Terrone C
BJU Int; 2013 Aug; 112(3):386-93. PubMed ID: 23496755
[TBL] [Abstract][Full Text] [Related]
20. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
